vs
Side-by-side financial comparison of Karyopharm Therapeutics Inc. (KPTI) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.
Karyopharm Therapeutics Inc. is the larger business by last-quarter revenue ($34.1M vs $22.7M, roughly 1.5× R F INDUSTRIES LTD). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -299.9%, a 300.6% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs 11.6%). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs 1.4%).
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
KPTI vs RFIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.1M | $22.7M |
| Net Profit | $-102.2M | $173.0K |
| Gross Margin | — | 36.8% |
| Operating Margin | -52.4% | 4.0% |
| Net Margin | -299.9% | 0.8% |
| Revenue YoY | 11.6% | 22.9% |
| Net Profit YoY | -232.0% | 172.7% |
| EPS (diluted) | $-7.02 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.1M | $22.7M | ||
| Q3 25 | $44.0M | $19.8M | ||
| Q2 25 | $37.9M | $18.9M | ||
| Q1 25 | $30.0M | $19.2M | ||
| Q4 24 | $30.5M | $18.5M | ||
| Q3 24 | $38.8M | $16.8M | ||
| Q2 24 | $42.8M | $16.1M | ||
| Q1 24 | $33.1M | $13.5M |
| Q4 25 | $-102.2M | $173.0K | ||
| Q3 25 | $-33.1M | $392.0K | ||
| Q2 25 | $-37.3M | $-245.0K | ||
| Q1 25 | $-23.5M | $-245.0K | ||
| Q4 24 | $-30.8M | $-238.0K | ||
| Q3 24 | $-32.1M | $-705.0K | ||
| Q2 24 | $23.8M | $-4.3M | ||
| Q1 24 | $-37.4M | $-1.4M |
| Q4 25 | — | 36.8% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | — | 29.8% | ||
| Q4 24 | — | 31.3% | ||
| Q3 24 | — | 29.5% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | — | 24.5% |
| Q4 25 | -52.4% | 4.0% | ||
| Q3 25 | -34.6% | 3.6% | ||
| Q2 25 | -64.3% | 0.6% | ||
| Q1 25 | -110.8% | 0.3% | ||
| Q4 24 | -102.4% | 0.5% | ||
| Q3 24 | -67.8% | -2.5% | ||
| Q2 24 | -65.7% | -2.6% | ||
| Q1 24 | -101.9% | -15.5% |
| Q4 25 | -299.9% | 0.8% | ||
| Q3 25 | -75.2% | 2.0% | ||
| Q2 25 | -98.2% | -1.3% | ||
| Q1 25 | -78.2% | -1.3% | ||
| Q4 24 | -100.8% | -1.3% | ||
| Q3 24 | -82.7% | -4.2% | ||
| Q2 24 | 55.6% | -26.7% | ||
| Q1 24 | -112.8% | -10.1% |
| Q4 25 | $-7.02 | $0.01 | ||
| Q3 25 | $-3.82 | $0.04 | ||
| Q2 25 | $-4.32 | $-0.02 | ||
| Q1 25 | $-2.77 | $-0.02 | ||
| Q4 24 | $-2.33 | $-0.02 | ||
| Q3 24 | $-3.85 | $-0.07 | ||
| Q2 24 | $-2.97 | $-0.41 | ||
| Q1 24 | $-4.85 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.5M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-292.9M | $35.2M |
| Total Assets | $108.4M | $73.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.5M | $5.1M | ||
| Q3 25 | $37.7M | $3.0M | ||
| Q2 25 | $38.7M | $3.6M | ||
| Q1 25 | $38.8M | $1.3M | ||
| Q4 24 | $62.5M | $839.0K | ||
| Q3 24 | $72.8M | $1.8M | ||
| Q2 24 | $84.8M | $1.4M | ||
| Q1 24 | $30.6M | $4.5M |
| Q4 25 | $-292.9M | $35.2M | ||
| Q3 25 | $-269.3M | $34.8M | ||
| Q2 25 | $-238.9M | $34.2M | ||
| Q1 25 | $-205.9M | $34.2M | ||
| Q4 24 | $-186.0M | $34.1M | ||
| Q3 24 | $-159.6M | $34.1M | ||
| Q2 24 | $-132.1M | $34.6M | ||
| Q1 24 | $-169.0M | $38.7M |
| Q4 25 | $108.4M | $73.0M | ||
| Q3 25 | $96.2M | $73.2M | ||
| Q2 25 | $104.9M | $72.7M | ||
| Q1 25 | $127.7M | $70.4M | ||
| Q4 24 | $164.4M | $71.0M | ||
| Q3 24 | $189.5M | $71.9M | ||
| Q2 24 | $214.0M | $72.8M | ||
| Q1 24 | $204.5M | $79.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.8M | $2.1M |
| Free Cash FlowOCF − Capex | — | $2.0M |
| FCF MarginFCF / Revenue | — | 9.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 12.13× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.8M | $2.1M | ||
| Q3 25 | $-5.9M | $-311.0K | ||
| Q2 25 | $-18.7M | $2.2M | ||
| Q1 25 | $-39.0M | $601.0K | ||
| Q4 24 | $-25.8M | $-244.0K | ||
| Q3 24 | $-19.5M | $2.4M | ||
| Q2 24 | $-38.5M | $197.0K | ||
| Q1 24 | $-43.7M | $840.0K |
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $-419.0K | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $574.0K | ||
| Q4 24 | $-25.9M | $-418.0K | ||
| Q3 24 | — | $2.1M | ||
| Q2 24 | — | $28.0K | ||
| Q1 24 | $-43.9M | $697.0K |
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | -2.1% | ||
| Q2 25 | — | 11.4% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | -84.7% | -2.3% | ||
| Q3 24 | — | 12.6% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | -132.6% | 5.2% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.2% | 0.9% | ||
| Q3 24 | 0.0% | 1.5% | ||
| Q2 24 | 0.0% | 1.0% | ||
| Q1 24 | 0.6% | 1.1% |
| Q4 25 | — | 12.13× | ||
| Q3 25 | — | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.62× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
